Different 2-Aminothiazole Therapeutics Produce Distinct Patterns of Scrapie Prion Neuropathology in Mouse Brains

Kurt Giles(United States Nuclear Regulatory Commission), David B. Berry(United States Nuclear Regulatory Commission), Carlo Condello(United States Nuclear Regulatory Commission), Ronald C. Hawley(United States Nuclear Regulatory Commission), Alejandra Gallardo‐Godoy(United States Nuclear Regulatory Commission), Clifford Bryant(United States Nuclear Regulatory Commission), Abby Oehler(United States Nuclear Regulatory Commission), Manuel Elepano(United States Nuclear Regulatory Commission), Sumita Bhardwaj(United States Nuclear Regulatory Commission), Smita S. Patel(United States Nuclear Regulatory Commission), B. Michael Silber(United States Nuclear Regulatory Commission), Shenheng Guan(United States Nuclear Regulatory Commission), Stephen J. DeArmond(United States Nuclear Regulatory Commission), Adam R. Renslo(United States Nuclear Regulatory Commission), Stanley B. Prusiner(United States Nuclear Regulatory Commission)
Journal of Pharmacology and Experimental Therapeutics
July 30, 2015
Cited by 57Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis